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Abstract
A 66-year-old female patient was admitted to our department with a large tumor of the tongue
measuring 10 cm in diameter. The tumor occupied nearly the entire oral cavity and showed
exophytic and ulcerative areas. Histological analysis revealed a low grade squamous cell carcinoma
(SCC) of the tongue. Bilateral enlarged cervical lymphatic masses were also present. The extent of
the tumor infiltration was assessed by fluoro-2-deoxy-glucose-positron emission tomography
(PET) scans showing an elevated activity of the tracer corresponding to the assumed cervical
metastases. Additionally, pulmonary metastases were identified. Contrast enhanced computed
tomography (CT) scans showed metastases in the soft tissues of the abdomen, legs and arms. Foci
of distant metastases were found in the left upper anterior thoracal wall, near the intraabdominal
portion of the aorta, near the right iliac crest and in both the right vastus medialis- and adductor
magnus muscles. The final diagnosis was a T4N3M1(G3)(C3) SCC of the tongue with multiple
distant thoracal, abdominal and intramuscular metastases. The survival expectancy was five weeks,
and the patient finally deceased by cardiopulmonary complications.
Background
Patients suffering from a squamous cell carcinoma (SCC)
of the head and neck region with distant metastases gen-
erally have a very poor prognosis [1]. Distant metastases
typically manifest themselves in the lung, bones, liver and
skin. Only few articles have been reported on a different
localization of distant metastases. Moriya et al. (2004)
recently reported on a patient suffering from a cardial
metastasis of an oral SSC together with additional metas-
tases in the liver, lung, spleen and kidneys [2]. A distant
metastasis in the gluteal muscle of a 65-year-old patient
suffering from a SSC of the larynx has been recently
described [3]. Oo et al. (2004) have identified three
patients with metastases in the axillary lymph nodes over
a period of 20 years [4]. In these three case reports, the pri-
mary malignoma were identified as carcinomas within a
pleomorphous adenoma of the parotideal gland, a SCC of
the tongue and a SCC of the anterior floor of the mouth,
respectively. Mess et al. (1986) have reported on distant
metastases which were localized in the carpal bones of the
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knowledge, no case has been reported up to date on the
manifestation of distant metastases of a SCC in the soft
tissue of the extremities.
In summary, we report on a 66-year-old female patient
who suffered from a terminal SCC of the tongue with mul-
tiple distant metastases which were localized mainly in
the peripheral skeletal muscles and adjacent soft tissues of
the lower extremities. Furthermore, we show an overview
on the current literature on metastases originating from
head and neck tumors [Table 1].
Case presentation
A 66-year-old woman was admitted with the symptoms of
acute dyspnoe, orthopnoe and progressive dysphagia. The
inspection of the oral cavity revealed an extensive lesion
of the tongue (Fig. 1) with areas of exophytic growth of
the tumor as well as a large ulcus located at the dorsal part
of the tongue. This large tumor of the tongue occupied
nearly the whole oral cavity and the anterior part of the
tongue's margin clearly showed biting traces. These
inspectatory findings were accompanied by a respective
halitosis. Both the general and nutritional status of the
patient were clearly reduced with a body mass index
(BMI) of 15.6 kg/m2 (body weight of 40 kg and height of
1.60 m). The medical examination revealed the presence
of bilateral large cervical conglomerates of lymph nodes
that sonographically measured 6 cm in diameter. An acute
obstruction of the upper airway by the tumor mass could
be excluded by native computed tomography (CT) imag-
ing of the neck and therefore a tracheotomy was not per-
formed. At admission, the diameter of the tumor was
already greater than 10 cm (Fig. 2). At the same time, a
bioptic tissue probe was analyzed histologically and
revealed a low grade differenciated (G3) SCC (Fig. 3).
Table 1: Survey of the literature
Authors Cases Results (localization of distant metastases in %)
Probert et al. 1974 [24] 96 Patients with SCC, 31% OSCC lung 65%, bone 25%, liver 24%, skin 14%, brain 13%, adrenal 8%, heart 
7%, kidney 6%, peritoneum, mediastinum and soft tissue each 5%, 
esophagus 4%, spleen 3%, bone marrow 3%, thyroid 2%, prostate 1% 
and middle ear 1%.
Merino et al. 1977 [25] 546 patients with SCC, 21% OSCC primary tumor orally or in the oropharynx: lung 52%, bone 20.3%, 
liver 6%, mediastinum 2.9%, lung and bone 3.3% and others 15.4%. 
Primary tumor in the nasopharynx: bone 54%, lung 23.8%; primary 
tumors of the fossa tonsillaris and of the basis of the tongue: 
metastases were primarily found in the liver (22% and 10.8% 
respectiveliy)
Papac et al. 1984 [26] 52 patients with SCC, 4% at the bottom 
of the oral cavity, 10% tumors of the 
tongue
lung 75%, bone 44%, liver 17%, skin 13%, brain 13%, adrenal 6%, heart 
8%, kidney 10%, GIT 15%, mediastinum 10%, spleen 3% and thyroid 
6%.
Troell et al. 1995 [27] 79 patients with SCC with a total of 145 
remote metastases.
lung 45, bone 27, liver 11, mediastinum 10 and other localisations 
(adrenal, brain, pericard, kidney and thyroid) 7.
De Bree et al. 2000 [28] 17 patients with SCC, 34% OSCC lung 71%, mediastinum 24%, bone 24% and liver 6%.
Leon et al. 2000 [29] 64 patients with SCC, 2% OSCC lung/mediastinum 52%, bone 12%, liver 5%, a combination of lung 
with bone and liver or skin 31%.
Kowalski et al. 2005 [30] 89 patients with distant metastases 
coming from oral or oropharyngeal SCC.
lung 58.4%, bone 37.1%, liver 3.4%, brain 3.4%, soft tissue 2.2%, 
peritoneum 1.1%, mediastinum 1.1%, axillary lymph nodes 1.1%, lung 
combined with bone 5,6%, lung combined with liver 1.1% and lung 
combined with brain 1.1%.
Alvarez Marcos et al. 2006 [31] 39 patients with SCC, 26% OSCC lung 58%, bone 22%, liver 9%, soft tissue 9% and others 2%.
Abbreviations: SCC = squamous cell carcinoma.
Intraoral photography: Tumor of the tongue with bite marks at the margin, filling the oral cavityFigure 1
Intraoral photography: Tumor of the tongue with bite marks 
at the margin, filling the oral cavity.Page 2 of 7
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emission tomography (18F-FDG-PET; Fig. 4, 5) scans
showed cervical hypermetabolic foci along the nerve-ves-
sel-sheaths of both sides that were suspect for malignancy
and assessed as metastases with regard to sensitivity and
specifity of PET and CT scan. Multiple metastatic lesions
were also present in the lung. Furthermore, foci that were
suspect for metastases were also found unilaterally in the
muscular system of both the left part of the back and left
anterior thoracic wall. On the basis of these rather atypical
findings, we performed a total body CT in order to exclude
the simultaneous presence of a second malignoma.
Altogether, one suspect soft tissue metastasis could be
identified near the left upper ventral thoracal wall (Fig. 6).
Contrast enhanced CT, soft tissue window: Tumor of the tongue (10 cm) with a large lymphe no e metastasis near the right cervical vessel-nerve-sheath (red arrow)Figu  2
Contrast enhanced CT, soft tissue window: Tumor of the 
tongue (10 cm) with a large lymphe node metastasis near the 
right cervical vessel-nerve-sheath (red arrow).
Histology: normal squamous epithelium (red arrows); carci-noma showing immature cells without ke atosis which corre-spond  t  a G3-grading (hematoxylin and eosin (HE) staining; magnificatio : 100×)Figure 3
Histology: normal squamous epithelium (red arrows); carci-
noma showing immature cells without keratosis which corre-
sponds to a G3-grading (hematoxylin and eosin (HE) staining; 
magnification: 100×).
Imaging by fluorine 18-fluoro-2-deoxy-glucose-positron e ission tom graphy (18F-FDG-PET) lateral viewFigure 5
Imaging by fluorine 18-fluoro-2-deoxy-glucose-positron 
emission tomography (18F-FDG-PET) lateral view.
Imaging by fluorine 18-fluoro-2-deoxy-glucose-positron e ission tom graphy (18F-FDG-PET) anterior-pos erior viewFigure 4
Imaging by fluorine 18-fluoro-2-deoxy-glucose-positron 
emission tomography (18F-FDG-PET) anterior-posterior 
view.Page 3 of 7
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dal of the sterno-costal base of the first rib in close vicinity
to the internal mammary artery. Another metastasis
emerged within the thoracic cavity in the right paraaortal
soft tissue sheath. A metastasis measuring approximately
1 cm in diameter was detected in the right iliocostal lum-
borum muscle near the pelvic rim (Fig. 7). In the right vas-
tus medialis/intermedius muscle one soft tissue
metastasis of a diameter of several centimeters was found
(Fig. 8). Also, more caudal, a metastasis of approx. 1 cm
in diameter was shown in the right adductor magnus mus-
cle. In the long head of the left biceps femoris muscle
another metastasis measuring a few millimeters was iden-
tified.
In summary, the tumor staging according to the UICC
(Union internationale contre le cancer) revealed a termi-
nal cT4cN3cM1(G3)(C3) tumor. At this advanced stage,
surgical therapy with curative intention was not indicated.
At the same time, the patient strictly refused a surgical
reduction of the tumor, a palliative radiochemotherapy as
well as the application of a PEG-device. Therefore, she was
transferred to the palliative care unit. The patient finally
deceased after 5 weeks of hospitalization by a cardiopul-
monary failure as a consequence of the tumor progres-
sion. The histologic confirmation of the suspect radiologic
diagnoses, which included the spreading of the neoplasia,
could be made only for the intraoral findings within the
limits of the primary diagnostics, because the patient's rel-
atives did not consent to perform an autopsy despite our
request.
Conclusion
Importantly, in the case presented here, the pattern of an
advanced hematogenous spreading of metastases is partic-
ular. The metastases were located mainly in the soft tissues
of the lower extremities, in particular in the skeletal mus-
cular system. A few small metastasis-like lesions were also
found in the cardiopulmonary system, as shown by 18F-
FDG-PET imaging and CT scans, but they were clearly of
Contrast enhanced CT, soft tissue window: Soft tissue metastasis at the left upper ventral throracic wallFigu e 6
Contrast enhanced CT, soft tissue window: Soft tissue 
metastasis at the left upper ventral throracic wall.
Contrast enhanced CT, soft tissue window: Soft tissue metastasis (1 cm) in the ilioco tal lumborum muscle on the right sideFigu e 7
Contrast enhanced CT, soft tissue window: Soft tissue 
metastasis (1 cm) in the iliocostal lumborum muscle on the 
right side.
Contrast enhanced CT, soft tissue window: Soft tissue metastasis in the right vastus medialis/intermedius m sclesFigu e 8
Contrast enhanced CT, soft tissue window: Soft tissue 
metastasis in the right vastus medialis/intermedius muscles.Page 4 of 7
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tases in the peripheral skeletal muscles and adjacent soft
tissues.
The patient did not show any cardiac lesion in the CT
scans. Thus, in case of the presence of masses of unknown
origin in the lower extremities in patients who once suf-
fered or are still suffering from a SCC of the oral cavity, a
possible spreading of metastases should be taken into
consideration. We would like to point out that the exam-
ination for such findings should be performed during the
continuous tumor recall and control appointments. In the
case presented here, a native computertomography of the
neck was initially performed. It showed no obstruction or
imminent obstruction of the airways. Therefore a trache-
otomy was abstained from. In general and in accordance
with the current literature, the authors prefer a preopera-
tive tracheotomy in order to avoid postoperative airway
difficulties and a tracheotomy in an emergeny setting [6].
In the case of the patient presented here, the quality of life
was limited mainly by the tumor of the tongue causing
impaired ability to swallow, reduced function of speech
and impairment by esthetic and functional disfigurement,
three factors that contributed to a low quality of life in a
considerable degree. Not the distant metastases were the
life-limiting factor, but rather the extensive local findings
in the oral cavity which caused considerable respiratory
and nutritional limitations. A valuable alternative for
patients with a stage IV tumor disease with distant metas-
tases, where the primary tumor is mostly considered to be
the survival-limiting factor, is to offer them both an
immediate therapy of the primary tumor and an integral
palliative care in order to improve the quality of life.
Other authors also support these recommendations; e.g.,
it has recently been shown that patients whose loco-
regional and remote metastases were operated had a high
two-year surviving rate [7]. This kind of tumor-debulking
operations cause important defects in the orofacial area
and should often be covered by microsurgical flaps. If the
patient shows a rather reduced general state of health, any
tumor-debulking operation should probably be excerted
in a two-timed planning concept to minimize the opera-
tive risk. Other authors have recently reported that imme-
diate microsurgical reconstructions could be beneficial in
palliative situations [8,9].
It has recently been reported that some patients who suf-
fered an untreated SCC of the head and neck region sur-
vived for more than five years. Studies in which the
outcome of patients with a SCC who were not treated at
all were compared to the outcome of patients who under-
went a palliative therapy showed that the mean survival
rate was 8.4 months larger in patients who underwent a
palliative therapy [10]. However, other authors reported
on prolonged surviving rates in some cases of untreated
tumors of the head and neck [11-14]. Kowalski and Car-
valho (2000, 2001) analyzed in a long-lasting retrospec-
tive study from 1953 to 1990 the clinical outcome of 808
patients with an untreated tumor of the head and neck
[15,16]. They reported that, in accordance with the above
findings, patients, who did not receive any treatment, sur-
vived up to 4 years [16]. Therefore, it seems to be difficult
to anticipate the rate of survival by using subjective or
objective criteria. The author reports that nearly 50% of
patients with an untreated tumor in the head and neck
region deceased within the first four month after the diag-
nosis had been made and given to the patient. Surpris-
ingly, some patients survived more than four years and
the author reported that the factors which had a signifi-
cant impact on survival were localization of the tumor,
tumor staging and scoring the performance of the
patients.
Rapoport et al. (1975) compared recurring head and neck
tumors in relation to the outcome [17]. One group under-
went chemotherapy whereas the control group received a
placebo treatment. They concluded that chemotherapy
considerably improved the quality of life, but did not pro-
long the time of survival. New therapeutic strategies such
as treatment of head and neck tumors with hyperfrac-
tional radiotherapy followed by chemotherapy showed
five-year survival rates of more than 40% [18-20]. In con-
sideration of these survival rates, Kowalski et Carvalho
(2001) suggested that new treatment approaches should
be offered to all patients and should start as early as pos-
sible after having given the diagnosis to the patient. This
is important because the mean time period which a tran-
sition from a terminal to an untreatable tumor takes is
considered to be only 3.8 months [16].
The studies cited here support the ruling opinion that a
meticulous staging is an essential aspect within the con-
trol of survival rates and quality of life. If the patient, as in
the case presented here, refuses biopsy of suspected
peripheral metastases, further costs can evolve later when
other apparative examination means become necessary.
This should be avoided, if possible, by an appropriate
early education and guidance of the patient. However, the
clinician is often confronted with the delicate task to
choose a reasonable balance between minimal and maxi-
mal diagnostic means that are available and treat the
patient with respect, which is a basic requirement. A PET-
CT Scan could have been a cost saving, sufficient alterna-
tive. According to Nahmias et al. (2007), it shows a specif-
icity of 99% and a sensitivity of 48% in a preoperative
lymph node staging of the neck with oral squamous cell
carcinoma. A positive PET-CT scan has a high positive pre-
dictive value [21]. Although the low sensitivity doesn't
really help the surgeon in the decision, whicht lymphPage 5 of 7
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neck dissection, the surgeon shoud not depend on the
PET-CT scan only. However, there are positive results in
detecting remote metastases by PET-CT scans in other
studies [22]. Schneider et al. (2006) report on the ameni-
ties of the PET-CT scan because of the exact anatomical
representation in cases of the CUP-syndrome (cancer of
unknown primary-syndrome) in order to find the primary
tumor and in the diagnostic of a relapse in tumor aftercare
[23]. All the authors mentioned above warn about false
positive results, which can have drastic implications on
the quality of life of the affected patient. PET-CT Scans are
expensive and their use has to be limited to the proper
indications. In the years to come, it will be a challenge for
the professional medical associations to find consents
that are consistent with both saving and optimizing the
costs and taking into consideration the individual needs
of the patients.
In conclusion, we point out that distant metastases of
SCC's of the head and neck region can manifest them-
selves in the peripheral skeletal muscles and adjacent soft
tissues. Therefore, during performing a tumor staging and
during aftercare, this possible localization of metastases
should be taken into consideration if suspect lesions were
found in the peripheral skeletal muscles and nearby soft
tissues in a patient who suffers from or who had once suf-
fered from a SCC. It has to be considered that distant
metastases of head and neck tumors are probably not the
limiting factor for the patient's survival prognosis since
the local primary tumors in the oral cavity can impor-
tantly impair nutrition and breathing. Therefore, an early
operative treatment should be an option for patients suf-
fering from a progressive and terminal head and neck
tumor, as a considerable good life expectancy can gener-
ally result and as the quality of life can be improved or at
least upheld on an acceptable level as long as possible.
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